Hims & Hers Raises Annual Forecast Revenue on Strong Subscriber Growth
Investors will watch whether revenue reaches $680 million to $700 million and gross margins stabilize after the company’s shift to branded GLP-1 drugs.
6 Articles
6 Articles
Hims & Hers Q2 Earnings Preview: Options Traders Brace for a 14.5% Move in HIMS Stock
Telehealth platform Hims & Hers Health (HIMS) will announce its second-quarter results on August 10. HIMS stock rose 6.5% to close at $31.59 on Friday. The options market is pricing in about a 14.50% move in either direction, implying a volatile reaction in HIMS stock in reaction to Q2 2026 earnings.Claim 55% Off TipRanks Importantly, an options-implied move measures the expected magnitude of the stock’s move after earnings, not whether it will …
Hims & Hers raises annual forecast revenue on strong subscriber growth
NEW YORK, Aug 10 (Reuters) - Hims & Hers Health on Monday posted second-quarter revenue above estimates and raised its annual revenue forecast, as the telehealth company benefited from an increase in subscribers and expanding its personalized healthc...
Will Hims & Hers Rebound After Tonight's Q2 Earnings?
Prediction markets favor another miss, Wall Street sees downside, and Reddit has gone bearish, yet one strong quarter could erase all of it. Follow live updates as Hims and Hers reports Q2 results after the bell tonight.
Hims & Hers Shares Drop After Beating Revenue Forecast With $753 Million, Margins Narrow
NEW YORK, August 10, 2026, 16:34 EDT – Shares in Hims & Hers fell after the company reported revenue of $753 million, topping estimates, as profit margins tightened. Shares of Hims & Hers Health (NYSE:HIMS) declined 5.8% in after-hours trading to $29.92.Revenue for the second quarter increased by 38% to $753.2 million, surpassing analysts' projection…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
